BioSpace News Archive

BioMidwest

Ultra-high-res MRI Reveals Migraine Brain Changes

For the first time, a new study has identified enlarged perivascular spaces in the brains of migraine sufferers.

November 23, 2022
·
4 min read
BioMidwest

Researchers Identify Brain Markers of ADHD in Children

Researchers analyzing the data from MRI exams on nearly 8,000 children have identified biomarkers of attention-deficit/hyperactivity disorder and a possible role for neuroimaging machine learning to help with the diagnosis, treatment planning and surveillance of the disorder.

November 23, 2022
·
3 min read
Business

The Native Antigen Company Strengthens Senior Team to Support Growing Product Portfolio

The Native Antigen Company, one of the world’s leading suppliers of reagents that enables research into vaccines and diagnostics for emerging and endemic infectious diseases, announced two key appointments to its management team.

November 23, 2022
·
3 min read
Business

Xeris Biopharma Announces Research Collaboration and Option Agreement With Horizon Therapeutics plc for XeriJect™ Formulation of Teprotumumab

Xeris Biopharma Holdings, Inc. today announced that it has entered into a research collaboration and option agreement with Horizon Therapeutics plc (Nasdaq: HZNP).

November 23, 2022
·
7 min read
FDA

Ascletis Announces IND Approval of Oral 3CLpro Inhibitor ASC11 for COVID-19 by U.S. FDA

Ascletis Pharma Inc. (HKEX: 1672, “Ascletis”) announces today that the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application of ASC11, an oral inhibitor drug candidate targeting 3-chymotrypsin like protease (3CLpro) for COVID-19.

November 23, 2022
·
3 min read
Genetown

Sage Therapeutics to Present at the Piper Sandler 34th Annual Healthcare Conference

Sage Therapeutics, Inc. announced today that the Company will present at the Piper Sandler 34th Annual Healthcare Conference on Thursday, December 1, 2022, at 8:00 a.m. ET in New York, NY.

November 23, 2022
·
1 min read
Genetown

TCR² Therapeutics to Present at the Piper Sandler Healthcare Conference

TCR 2 Therapeutics Inc. today announced that management will participate in a fireside chat at the 34th Annual Piper Sandler Healthcare Conference on Tuesday, November 29 at 2:00PM E.T.

November 23, 2022
·
1 min read
BioCapital

Immunocore to present at the 5th Annual Evercore ISI HealthCONx Conference

Immunocore Holdings Plc today announced that management will participate in a fireside chat at the 5th Annual Evercore ISI HealthCONx Conference.

November 23, 2022
·
1 min read
Biotech Bay

Sutro Biopharma to Participate in Upcoming Investor Conferences

Sutro Biopharma, Inc. today announced that Bill Newell, Chief Executive Officer, will participate in two upcoming investor conferences.

November 23, 2022
·
2 min read
Pharm Country

Tonix Pharmaceuticals to Participate in the A.G.P. Biotech Conference

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a clinical-stage biopharmaceutical company, announced today that management will participate virtually in the A.G.P. Biotech Conference and host investor meetings. The conference is being held Wednesday, November 30, 2022 – Thursday, December 1, 2022.

November 23, 2022
·
4 min read